Autonomous Functions of Structural Domains on Human Tissue-type Plasminogen Activator
Overview
Authors
Affiliations
Transfected mouse Ltk- cells were employed for transient expression of recombinant human tissue-type plasminogen activator (t-PA; EC 3.4.21.31) or of recombinant-t-PA deletion proteins, encoded by SV40-pBR322-derived t-PA cDNA plasmids. The t-PA cDNA deletion mutants have two features in common, i.e., cDNA programming the signal peptide and the coding region for the light chain. Consequently, recombinant t-PA mutant proteins are efficiently secreted and display plasminogen activator activity. The gene encoding the amino-terminal heavy chain [an array of structural domains homologous to other plasma proteins (finger, epidermal growth factor, and kringle domains)] was mutated using restriction endonucleases to delete one or more structural domains. The stimulatory effect of fibrinogen fragments on the plasminogen activator activity of t-PA was demonstrated to be mediated by the kringle K2 domain and to a lesser extent by the finger/epidermal growth factor region but not by the kringle K1 domain. These data correlate well with the fibrin-binding properties of the recombinant t-PA deletion proteins, indicating that the stimulation of the activity by fibrinogen fragments is based on aligning the substrate plasminogen and t-PA on the fibrin matrix. Our results support the evolutionary concept of exon shuffling, arranging structural domains that constitute autonomous functions of the protein.
Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier.
Diaz A, Woo Y, Martin-Jimenez C, Merino P, Torre E, Yepes M J Cereb Blood Flow Metab. 2021; 42(4):667-682.
PMID: 34796748 PMC: 9051146. DOI: 10.1177/0271678X211060395.
Development and Testing of Thrombolytics in Stroke.
Nikitin D, Choi S, Mican J, Toul M, Ryu W, Damborsky J J Stroke. 2021; 23(1):12-36.
PMID: 33600700 PMC: 7900387. DOI: 10.5853/jos.2020.03349.
Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics.
Ghag G, Wolf L, Reed R, van der Munnik N, Mundoma C, Moss M Protein Eng Des Sel. 2016; 29(5):177-86.
PMID: 26957645 PMC: 4830411. DOI: 10.1093/protein/gzw005.
Novel actions of tissue-type plasminogen activator in chronic kidney disease.
Hu K, Mars W, Liu Y Front Biosci. 2008; 13:5174-86.
PMID: 18508579 PMC: 2650246. DOI: 10.2741/3073.
Weidner K, Sachs M, Birchmeier W J Cell Biol. 1993; 121(1):145-54.
PMID: 8384622 PMC: 2119778. DOI: 10.1083/jcb.121.1.145.